A critical assessment of SELDI-TOF-MS for biomarker discovery in serum and tissue of patients with an ovarian mass

BACKGROUND: Less than 25% of patients with a pelvic mass who are presented to a gynecologist will eventually be diagnosed with epithelial ovarian cancer. Since there is no reliable test to differentiate between different ovarian tumors, accurate classification could facilitate adequate referral to a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wegdam, Wouter, Moerland, Perry D, Meijer, Danielle, de Jong, Shreyas M, Hoefsloot, Huub C J, Kenter, Gemma G, Buist, Marrije R, Aerts, Johannes MF G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494530/
https://www.ncbi.nlm.nih.gov/pubmed/22824475
http://dx.doi.org/10.1186/1477-5956-10-45

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494530/
https://www.ncbi.nlm.nih.gov/pubmed/22824475
http://dx.doi.org/10.1186/1477-5956-10-45

Ejemplares similares